DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sun W, He B, Yang B. , et al.
Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma.
Lab Invest 2018;
98 (06) 734-744
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.